Study registry for young adults with pancreatic cancer
Part of Cancer clinical trials.
This study is a registry, meaning it collects information about young adults diagnosed with pancreatic cancer. It may help researchers better understand this cancer in younger people and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be diagnosed with pancreatic cancer (not another type of pancreatic tumor)
- You must be at least 18 years old at the time of diagnosis
- You must be 55 years old or younger at the time of diagnosis
- You must be able to sign a written consent form to join
- If you have a different pancreatic condition, you likely cannot join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry for people at high risk for pancreatic cancer. Researchers will collect information over time to learn more about how to detect and prevent the disease.
This study collects medical information and tissue samples from people with gastrointestinal cancers (cancers of the stomach, colon, pancreas, or related organs). Researchers use this data to better understand these cancers and improve future treatments.
This is a research registry that collects information from adults with suspected or diagnosed pancreatic cancer. It may help doctors better understand the disease and improve care over time.
This is a registry that collects information from people who have a pancreatic disease. It may help doctors better understand different pancreatic conditions and improve future care.
This is a “registry” study that collects health information from adults with pancreatic ductal adenocarcinoma before starting treatment. It may help researchers better understand the disease and how patients are managed in real life.
This registry collects information about people with advanced pancreatic cancer who are receiving first-line palliative treatment. It helps doctors understand which treatment choices are used and how people do over time.
Hear when a new PDAC - Pancreatic Ductal Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.